Related references
Note: Only part of the references are listed.3D-quantitative structure-activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors
Xin Zheng et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells
Ilangovan Raju et al.
BIOLOGICAL CHEMISTRY (2016)
Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5
Lucas V. B. Hoelz et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Small-molecule factor D inhibitors targeting the alternative complement pathway
Jurgen Maibaum et al.
NATURE CHEMICAL BIOLOGY (2016)
Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics
Blake T. Riley et al.
SCIENTIFIC REPORTS (2016)
Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity
Juliana R. Oliveira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7
Dominique P. Arama et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel Retro-Inverso Peptide Inhibitor Reverses Angiotensin Receptor Autoantibody-Induced Hypertension in the Rabbit
Hongliang Li et al.
HYPERTENSION (2015)
Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics
Yijing Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Independent Metrics for Protein Backbone and Side-Chain Flexibility: Time Scales and Effects of Ligand Binding
Julian E. Fuchs et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library
Simon J. de Veer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Binding properties of SUMO-interacting motifs (SIMs) in yeast
Christophe Jardin et al.
JOURNAL OF MOLECULAR MODELING (2015)
Unleashing the therapeutic potential of human kallikrein-related serine proteases
Ioannis Prassas et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Toward the First Class of Suicide Inhibitors of Kallikreins Involved in Skin Diseases
Xiao Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Characterizing Protease Specificity: How Many Substrates Do We Need?
Michael Schauperl et al.
PLOS ONE (2015)
Enhanced Sampling in Molecular Dynamics Using Metadynamics, Replica-Exchange, and Temperature-Acceleration
Cameron Abrams et al.
ENTROPY (2014)
Structure-Function Analyses of Human Kallikrein-related Peptidase 2 Establish the 99-Loop as Master Regulator of Activity
Wolfgang Skala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The ChEMBL bioactivity database: an update
A. Patricia Bento et al.
NUCLEIC ACIDS RESEARCH (2014)
Conformational Selection Is a Dominant Mechanism of Ligand Binding
Austin D. Vogt et al.
BIOCHEMISTRY (2013)
1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases
Xiao Tan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Vaspin inhibits kallikrein 7 by serpin mechanism
John T. Heiker et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Daniel R. Roe et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
Romelia Salomon-Ferrer et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Michael Zahn et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Old genes and new genes: The evolution of the kallikrein locus
Ake Lundwall
THROMBOSIS AND HAEMOSTASIS (2013)
Cleavage Entropy as Quantitative Measure of Protease Specificity
Julian E. Fuchs et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Biomolecular Simulation: A Computational Microscope for Molecular Biology
Ron O. Dror et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
Isomannide derivatives as new class of inhibitors for human kallikrein 7
Renato F. Freitas et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics
Levi C. T. Pierce et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
A Reverse Binding Motif That Contributes to Specific Protease Inhibition by Antibodies
Eric L. Schneider et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2012)
Dynamic Regulation of Phenylalanine Hydroxylase by Simulated Redox Manipulation
Julian E. Fuchs et al.
PLOS ONE (2012)
Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector
Ana C. Figueiredo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7
Thiago S. P. Teixeira et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Cell adhesion and communication proteins are differentially expressed in melanoma progression model
Gisele Gargantini Rezze et al.
HUMAN PATHOLOGY (2011)
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
Peter Goettig et al.
BIOCHIMIE (2010)
Isolation of SPINK6 in Human Skin SELECTIVE INHIBITOR OF KALLIKREIN-RELATED PEPTIDASES
Ulf Meyer-Hoffert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Emerging principles in protease-based drug discovery
Marcin Drag et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Atomic-Level Characterization of the Structural Dynamics of Proteins
David E. Shaw et al.
SCIENCE (2010)
A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15
Hyesook Yoon et al.
BIOLOGICAL CHEMISTRY (2009)
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
M. Talieri et al.
BRITISH JOURNAL OF CANCER (2009)
Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures
Paul Labute
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
Mekdes Debela et al.
BIOLOGICAL CHEMISTRY (2008)
Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E-coli:: Insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6)
Israel S. Fernandez et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition
Christopher J. Farady et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Dynamic personalities of proteins
Katherine Henzler-Wildman et al.
NATURE (2007)
Activation profiles and regulatory cascades of the human kallikrein-related peptidases
Hyesook Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7
Mekdes Debela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control I desquamation through a pH-dependent interaction
Celine Deraison et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
Kenshi Yamasaki et al.
NATURE MEDICINE (2007)
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
Sarah K. Johnson et al.
CANCER (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences
Mekdes Debela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
Loyse M. Felber et al.
FEBS JOURNAL (2006)
Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity
P Descargues et al.
NATURE GENETICS (2005)
A proteolytic cascade of kallikreins in the stratum corneum
M Brattsand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7
C Caubet et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
SM Cloutier et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
The design, synthesis and application of stereochemical and directional peptide isomers: A critical review
PM Fischer
CURRENT PROTEIN & PEPTIDE SCIENCE (2003)
Structural basis for the inhibition of caspase-3 by XIAP
SJ Riedl et al.
CELL (2001)
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family -: genomic characterization, mapping, tissue expression and hormonal regulation
GM Yousef et al.
GENE (2000)
Conformational selection of inhibitors and substrates by proteolytic enzymes: Implications for drug design and polypeptide processing
DP Fairlie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
